OVA1 or ROMA for Ovarian Cancer Screening

OVA1 has been FDA cleared for use in women who meet specific criteria. OVA1 is not intended to be a screening test or to determine whether a patient should proceed to surgery.  It can, however, be used as a tool by the patient’s primary physician to decide if the referral for treatment of a mass should go to a gynecologist or a gyn-oncologist. Submit CPT code 84999 for OVA 1 and ROMA testing for ovarian cancer.  CGS will review the supporting documentation for individual claims to determine if the medical need is established.

CIGNA Government Services, MAC for Idaho, Kentucky and Ohio